Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Although psychostimulant is the first line of drug to treat Attention Deficit Hyperactivity
Disorder, (ADHD), actually there are 10-20% ADHD patient do not response well to current
medication. Most of parents of children with ADHD in Taiwan dislike to use psychostimulant.
We expect that GlyTI-M will have better efficacy than placebo to reduce ADHD symptoms. This
study will also help us to understand the mechanism of ADHD and give a way to develop new
drug and also a more possible way to treat ADHD children under 6 years old.